Markets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
All Features
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Overview
Buy Sell Zone
F&O
Financials
News
All
News
Earnings Calls
Corporate Announcements
Research Reports
Reports
Technicals
Technicals
Share Price History
Delivery
Shareholding
Shareholding
Monthly MF Holdings
Bulk Block Deals
Insider Trading & SAST
Deals
Bulk Block Deals
Insider Trading & SAST
Corporate Actions
All
Dividend
Bonus
Split
Rights
Board Meetings
Alerts
About
Lupin Ltd.
NSE: LUPIN
|
BSE: 500257
|
ISIN: INE326A01037
|
Industry: Pharmaceuticals
US FDA Approval
|
Mid-range Performer
1972.4000
13.10
(
0.67
%)
NSE
Oct 13, 2025
15:49 PM
Volume:
530.9K
Share on Facebook
Tweet
Share on LinkedIn
Share via Whatsapp
Lupin Ltd.
12 Aug 2021, 12:00AM
US FDA Approval
1972.40
0.67%
Lupin Ltd
Hold:
Lupin Ltd.
by
ICICI Securities Limited
Target: 1025
Target
ICICI Securities Limited
...
Lupin Ltd. has an
average target
of 2326.00 from 8 brokers.
More from Lupin Ltd.
Recommended
Market trades lower, Mankind Pharma to acquire branded generics business from arm for Rs 797 cr
Trendlyne Marketwatch |
13 Oct 2025, 03:37PM
Five Interesting Stocks Today - October 10, 2025
The Baseline |
10 Oct 2025
Lupin expects normalization by September quarter
|
17 Apr 2020